Compound Detail
CHEMBL1682292
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL1682292 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | CGIOVWDQDUIYCO-UHFFFAOYSA-N |
2
Targets
5
Activities
1
Assay Types
0
PK Parameters
1
Publications
0
Known Names
Molecular Properties
405.9
MW (Da)
4.85
ALogP
6
HBA
3
HBD
100.0
PSA (Ų)
0.41
QED
0
Ro5 Violations
5
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 5 meas. best 8.0
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Casein kinase II subunit alpha CHEMBL3629 | IC50 | 8.0 | 7.945 | 10.0 | 4 |
| Casein kinase II CHEMBL2095191 | IC50 | 7.89 | 7.89 | 13.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Casein kinase II subunit alpha | IC50 | = | 10.0 | nM | 8.0 | Modulation of Endogenous Assay: The human leukemia Jurkat T-cell line was mainta... | - |
| Casein kinase II subunit alpha | IC50 | = | 10.0 | nM | 8.0 | Modulation of Endogenous Assay: The human leukemia Jurkat T-cell line was mainta... | - |
| Casein kinase II | IC50 | = | 13.0 | nM | 7.89 | Inhibition of human recombinant CK2 by radiometric assay | 21316963 |
| Casein kinase II subunit alpha | IC50 | = | 13.0 | nM | 7.89 | In Vitro Cell-Free Assay: Test compounds in aqueous solution were added at a vol... | - |
| Casein kinase II subunit alpha | IC50 | = | 13.0 | nM | 7.89 | In Vitro Cell-Free Assay: Test compounds in aqueous solution were added at a vol... | - |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 21316963 | 10.1016/j.bmcl.2011.01.091 | Casein kinase II | 1 |
Data from ChEMBL 36 via Core Engine